Comment: Synopsys-Ansys deal shows complainants remain as key risk in China
A brewing antitrust review facing Synopsys's $35 billion acquisition of Ansys illustrates the key role Chinese complainants still play in global deals, however much China's antitrust regulator strives to restrict regulatory...To view the full article, register now.
Already a subscriber? Click here to view full article